For example, Lee et al, (2010) show that the glycoprotein 90K has antitumour activity in CRC cells suppressing Wnt/β-catenin signalling by ISGylation-dependent ubiquitination of β-catenin when interacting with CD9/CD82. This evidence concerns the gene CD9 and colorectal carcinoma.